These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24219503)

  • 1. Influence of gold nanoparticles on the kinetics of α-synuclein aggregation.
    Alvarez YD; Fauerbach JA; Pellegrotti JV; Jovin TM; Jares-Erijman EA; Stefani FD
    Nano Lett; 2013; 13(12):6156-63. PubMed ID: 24219503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naringenin-Functionalized Gold Nanoparticles and Their Role in α-Synuclein Stabilization.
    Maity A; Mondal A; Kundu S; Shome G; Misra R; Singh A; Pal U; Mandal AK; Bera K; Maiti NC
    Langmuir; 2023 May; 39(21):7231-7248. PubMed ID: 37094111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biasing the native α-synuclein conformational ensemble towards compact states abolishes aggregation and neurotoxicity.
    Carija A; Pinheiro F; Pujols J; Brás IC; Lázaro DF; Santambrogio C; Grandori R; Outeiro TF; Navarro S; Ventura S
    Redox Biol; 2019 Apr; 22():101135. PubMed ID: 30769283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary nucleation of monomers on fibril surface dominates α-synuclein aggregation and provides autocatalytic amyloid amplification.
    Gaspar R; Meisl G; Buell AK; Young L; Kaminski CF; Knowles TPJ; Sparr E; Linse S
    Q Rev Biophys; 2017 Jan; 50():e6. PubMed ID: 29233218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-Synuclein Aggregation Mechanism in the Presence of Nanomaterials.
    Malik SA; Mondal S; Atreya HS
    Biochemistry; 2024 May; 63(9):1162-1169. PubMed ID: 38668883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-Synuclein aggregation at low concentrations.
    Afitska K; Fucikova A; Shvadchak VV; Yushchenko DA
    Biochim Biophys Acta Proteins Proteom; 2019; 1867(7-8):701-709. PubMed ID: 31096048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-aggregation kinetics and intermediates of α-synuclein monitored by the ESIPT probe 7MFE.
    Fauerbach JA; Jovin TM
    Eur Biophys J; 2018 May; 47(4):345-362. PubMed ID: 29255947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric fluorescence detection of early stages in the amyloid protein aggregation of pyrene-labeled alpha-synuclein.
    Thirunavukkuarasu S; Jares-Erijman EA; Jovin TM
    J Mol Biol; 2008 May; 378(5):1064-73. PubMed ID: 18433772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single fibril growth kinetics of α-synuclein.
    Wördehoff MM; Bannach O; Shaykhalishahi H; Kulawik A; Schiefer S; Willbold D; Hoyer W; Birkmann E
    J Mol Biol; 2015 Mar; 427(6 Pt B):1428-1435. PubMed ID: 25659910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural insights into amyloid oligomers of the Parkinson disease-related protein α-synuclein.
    Gallea JI; Celej MS
    J Biol Chem; 2014 Sep; 289(39):26733-26742. PubMed ID: 25143382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of amyloid fibrils in Parkinson's disease using plasmonic chirality.
    Kumar J; Eraña H; López-Martínez E; Claes N; Martín VF; Solís DM; Bals S; Cortajarena AL; Castilla J; Liz-Marzán LM
    Proc Natl Acad Sci U S A; 2018 Mar; 115(13):3225-3230. PubMed ID: 29531058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural remodeling during amyloidogenesis of physiological Nα-acetylated α-synuclein.
    Gallea JI; Sarroukh R; Yunes-Quartino P; Ruysschaert JM; Raussens V; Celej MS
    Biochim Biophys Acta; 2016 May; 1864(5):501-10. PubMed ID: 26845568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinorganic chemistry of Parkinson's disease: structural determinants for the copper-mediated amyloid formation of alpha-synuclein.
    Binolfi A; Rodriguez EE; Valensin D; D'Amelio N; Ippoliti E; Obal G; Duran R; Magistrato A; Pritsch O; Zweckstetter M; Valensin G; Carloni P; Quintanar L; Griesinger C; Fernández CO
    Inorg Chem; 2010 Nov; 49(22):10668-79. PubMed ID: 20964419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The aggregation and fibrillation of alpha-synuclein.
    Fink AL
    Acc Chem Res; 2006 Sep; 39(9):628-34. PubMed ID: 16981679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Lipid Membranes on α-Synuclein Aggregation.
    Kurochka AS; Yushchenko DA; Bouř P; Shvadchak VV
    ACS Chem Neurosci; 2021 Mar; 12(5):825-830. PubMed ID: 33566579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The C-terminal α-helices of mammalian Hsc70 play a critical role in the stabilization of α-synuclein binding and inhibition of aggregation.
    Chaari A; Eliezer D; Ladjimi M
    Int J Biol Macromol; 2016 Feb; 83():433-41. PubMed ID: 26601760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of nanoparticles on amyloid peptide and protein aggregation: a review with a focus on gold nanoparticles.
    John T; Gladytz A; Kubeil C; Martin LL; Risselada HJ; Abel B
    Nanoscale; 2018 Dec; 10(45):20894-20913. PubMed ID: 30225490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of Noradrenaline to Native and Intermediate States during the Fibrillation of α-Synuclein Leads to the Formation of Stable and Structured Cytotoxic Species.
    Singh P; Bhat R
    ACS Chem Neurosci; 2019 Jun; 10(6):2741-2755. PubMed ID: 30917654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Optimization of Inhibitors of α-Synuclein Fibril Growth: Affinity to the Fibril End as a Crucial Factor.
    Afitska K; Priss A; Yushchenko DA; Shvadchak VV
    J Mol Biol; 2020 Feb; 432(4):967-977. PubMed ID: 31809698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Characteristics of α-Synuclein Oligomers.
    Cremades N; Chen SW; Dobson CM
    Int Rev Cell Mol Biol; 2017; 329():79-143. PubMed ID: 28109332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.